DexCom (DXCM) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
DexCom (DXCM) PT Raised to $130 at Morgan Stanley
August 3, 2018 7:46 AM EDTMorgan Stanley raised its price target on DexCom (NASDAQ: DXCM) to $130.00 (from $70.00) while maintaining a Equalweight rating.
... MoreDexCom (DXCM) PT Raised to $125 at Oppenheimer
August 2, 2018 9:29 AM EDTOppenheimer raised its price target on DexCom (NASDAQ: DXCM) to $125.00 (from $85.00) while maintaining an Outperform rating.
Analyst Steven Lichtman commented, "DexCom's 2Q18 sales of $243M (+41% cc) delivered a strong beat versus our/consensus $202/$206M forecasts, led by robust outperformance in both US and... More
DexCom (DXCM) PT Raised to $120 at Cowen Following 'Monster' Qtr
August 2, 2018 7:59 AM EDTCowen raised its price target on DexCom (NASDAQ: DXCM) to $120.00 (from $110.00) while maintaining a Outperform rating following its "huge" beat and raise.
Analyst Doug Schenkel commented, "DXCM posted a huge beat and raise. Deals with payers to expand access / simplify distribution could temper... More
